Aerie Pharmaceuticals Inc.

NAS: AERI

GO
/marketstate/country/us

Market open

/zigman2/quotes/200692066/composite

$

12.10

Change

+0.18 +1.51%

Volume

Volume 88,737

Sep 23, 2021, 10:35 a.m.

Real time quotes

/zigman2/quotes/200692066/composite

Previous close

$ 11.92

$ 12.10

Change

+0.18 +1.51%

Day low

Day high

$11.90

$12.22

Open
Open: 12.02

52 week low

52 week high

$9.01

$21.30

Open

Market cap

$563.03M

Average volume

593,621

P/E ratio

N/A

Rev. per Employee

$227,775

EPS

-3.61

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/aeri

MarketWatch News on AERI

  1. Aerie Pharmaceuticals downgraded to underperform from neutral at BofA Securities

    10:08 a.m. Oct. 19, 2020

    - Tomi Kilgore

  2. Aerie Pharmaceuticals stock price target cut to $34 from $54 at Mizuho

    7:12 a.m. April 13, 2020

    - Tomi Kilgore

  3. Aerie Pharmaceuticals started at buy with $32 stock price target at SunTrust RH

    9:55 a.m. Jan. 9, 2020

    - Tomi Kilgore

  4. Aerie Pharmaceuticals stock price target cut to $80 from $87 at Stifel Nicolaus

    7:42 a.m. July 10, 2019

    - Tomi Kilgore

  5. How to spot risky biotech companies and six to avoid now

    6:14 a.m. Jan. 17, 2019

    - Michael Brush

  6. Aerie Pharma eye drug Rhopressa approved by FDA

    5:47 p.m. Dec. 18, 2017

    - Jeremy C. Owens

  7. Aerie Pharmaceuticals stock halted ahead of announcement of FDA approval of Rhopressa

    5:07 p.m. Dec. 18, 2017

    - MarketWatch

  8. Aerie Pharmaceuticals stock halted as FDA committee reviews glaucoma treatment

    7:22 a.m. Oct. 13, 2017

    - Ciara Linnane

  9. Aerie Pharma stock surges 31% on positive late-stage trial results for glaucoma eye drops

    4:15 p.m. May 24, 2017

    - Emma Court

  10. Aerie Pharmaceuticals downgraded to market perform from strong buy at Raymond James

    8:58 a.m. March 9, 2017

    - Trey Williams

  11. Aerie Pharmaceuticals stock price target raised to $56 from $50 at Canaccord Genuity

    11:05 a.m. March 8, 2017

    - Tomi Kilgore

  12. VIX tags multi-year lows amid bullish S&P 500 technical breakout

    12:17 p.m. Jan. 27, 2017

    - Michael Ashbaugh

  13. Dow books 7th straight weekly gain in muted preholiday trade

    5:32 p.m. Dec. 23, 2016

    - Carla Mozee

  14. Aerie Stock Hits High, Holder Sells $2 Million

    11:52 a.m. Oct. 14, 2016

    - Barron's Online

  15. Aerie Pharma announces secondary offering after big stock jump

    5:17 p.m. Sept. 15, 2016

    - Wallace Witkowski

  16. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/aeri

Other News on AERI

  1. Warning: AERI has been downgraded to Very Bearish.

    4:25 a.m. Sept. 20, 2021

    - Seeking Alpha

  2. Aerie (AERI) Announces Mixed Data From Dry Eye Disease Study

    11:19 a.m. Sept. 16, 2021

    - Zacks.com

  3. Aerie Pharmaceuticals (AERI) Investor Presentation - Slideshow

    2:00 p.m. Sept. 10, 2021

    - Seeking Alpha

  4. Aerie's(AERI) Q2 Loss Wider Than Expected, Revenues Beat

    11:42 a.m. Aug. 5, 2021

    - Zacks.com

  5. 10-Q: AERIE PHARMACEUTICALS INC

    6:13 a.m. Aug. 5, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  6. Aerie Pharmaceuticals (AERI) Investor Presentation - Slideshow

    5:05 p.m. June 25, 2021

    - Seeking Alpha

  7. Why Is Aerie (AERI) Down 7.7% Since Last Earnings Report?

    11:31 a.m. June 4, 2021

    - Zacks.com

  8. 10-Q: AERIE PHARMACEUTICALS INC

    6:26 a.m. May 6, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  9. Loading more headlines...
/news/pressrelease/company/us/aeri

Press Releases on AERI

  1. Glaucoma Treatment Market Future Prospects 2026

    2:30 p.m. July 20, 2021

    - Market Insight Reports

  2. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/203240833/composite ASG-0.56%
  • /zigman2/quotes/200272047/composite OI-1.52%
  • /zigman2/quotes/201842100/composite DISCK-2.18%
  • /zigman2/quotes/208424563/composite GRFS-2.16%
  • /zigman2/quotes/202258849/composite COOP+2.03%
X
Powered by StockTwits
Link to MarketWatch's Slice.